Related references
Note: Only part of the references are listed.Requirement of the Akt/β-Catenin Pathway for Uterine Carcinosarcoma Genesis, Modulating E-Cadherin Expression Through the Transactivation of Slug
Makoto Saegusa et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-κB activation and invasive prostate carcinoma
Pablo J. Fernandez-Marcos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis
Jayashree Joshi et al.
EMBO JOURNAL (2008)
Overexpression of par-4 enhances thapsigargin-induced apoptosis via down-regulation of XIAP and inactivation of Akt in human renal cancer cells
Tae-Jin Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Transcription factor EgrI acts as an upstream regulator of β-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells
M. Saegusa et al.
JOURNAL OF PATHOLOGY (2008)
Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition
S. Julien et al.
ONCOGENE (2007)
A functional role of Cdx2 in β-catenin signaling during transdifferentiation in endometrial carcinomas
Makoto Saegusa et al.
CARCINOGENESIS (2007)
Inactivation of the candidate tumor suppressor Par-4 in endometrial cancer
Gema Moreno-Bueno et al.
CANCER RESEARCH (2007)
Induction of p16INK4A mediated by β-catenin in a TCF4-independent manner:: Implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells
Makoto Saegusa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland
Shen Gao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
The phosphoinositide 3-kinase/Akt1/Par-4 axis: A cancer-selective therapeutic target
A Goswami et al.
CANCER RESEARCH (2006)
Binding and phosphorylation of Par-4 by Akt is essential for cancer cell survival
A Goswami et al.
MOLECULAR CELL (2005)
Tumour-suppression activity of the proapoptotic regulator Par4
I García-Cao et al.
EMBO REPORTS (2005)
A portrait of AKT kinases - Human cancer and animal models depict a family with strong individualities
A Bellacosa et al.
CANCER BIOLOGY & THERAPY (2004)
Par-4 inducible apoptosis in prostate cancer cells
S Gurumurthy et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
β-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells
M Saegusa et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
DAP-like kinase, a member of the death-associated protein kinase family, associates with centrosomes, centromers, and the contractile ring during mitosis
U Preuss et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2003)
Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells
N El-Guendy et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Par-4 transcriptionally regulates bcl-2 through a WT1-binding site on the bcl-2 promoter
SK Cheema et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Apoptosis by Par-4 in cancer and neurodegenerative diseases
N El-Guendy et al.
EXPERIMENTAL CELL RESEARCH (2003)
Regulation of apoptosis in prostate cancer
S Gurumurthy et al.
CANCER AND METASTASIS REVIEWS (2001)
Four deaths and a funeral:: From caspases to alternative mechanisms
M Leist et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
